An article published by Nature earlier this year pointed out that researchers now have to worry about the reproducibility of production antibodies. The fact of the matter is that off-the-shelf antibodies from large distributors can be… Read More
ProScis 5 As of Antibody Development Infographic
Antibody development is multi-faceted process that begins with the target to which you wish to develop antibodies against: the antigen. To elicit an immune response we must select the appropriate adjuvant to be mixed with the antigen… Read More
Antibody Basics: Hybridoma
Hybridoma Development Hybridoma technology is the core technique used to develop monoclonal antibodies at ProSci. A hybridoma is a single cell that consists of a cancerous myeloma cell and an immune B-cell which have been fused together… Read More
Antibody Basics: Monoclonal, Polyclonal, and Recombinant Antibodies
While simple in principle, antibodies are deceivingly complex in structure and production. Do you know the advantages and disadvantages of monoclonal, polyclonal and recombinant antibody production? Let ProSci be your expert. Polyclonal → Monoclonal → Recombinant Polyclonal Antibodies: Polyclonal… Read More
Antibodies & Targets: An Introduction to SAMHD1
What Is the Structure of SAMHD1 and When is it Expressed? SAMHD1, or Sterile Alpha Motif and Histidine/Aspartate domain-containing protein 1, is a dimeric enzyme with phosphohydrolase and nuclease activity that functions as a blockade… Read More
Antibody Suppresses AIDS Virus
NIAID/AP An H9 T cell, blue, is shown infected with HIV, yellow. Researchers at Rockefeller University say a new antibody can be given to HIV patients years before their bodies would produce them naturally —… Read More
Does the Llama Hold the Key to HIV Vaccines?
Written by David Heitz | Published on December 18, 2014 Find this article and others like it on Healthline’s website here. Does Llama Blood Hold the Key to an HIV Vaccine? Llamas make especially tiny antibodies that… Read More